Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensus
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensus
Authors
Keywords
-
Journal
BMJ Open Diabetes Research & Care
Volume 8, Issue 1, Pages e001248
Publisher
BMJ
Online
2020-05-05
DOI
10.1136/bmjdrc-2020-001248
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Management of diabetes during Ramadan fasting in children and adolescents: A survey of physicians’ perceptions and practices in the Arab Society for Paediatric Endocrinology and Diabetes (ASPED) countries
- (2019) Nancy Elbarbary et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Diabetes and Ramadan: A multicenter study in Algerian population
- (2019) Rachid Malek et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Safety of lixisenatide versus sulfonylurea added to basal insulin treatment in people with type 2 diabetes mellitus who elect to fast during Ramadan (LixiRam): An international, randomized, open-label trial
- (2019) Mohamed M. Hassanein et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Risk of diabetic ketoacidosis during Ramadan fasting: A critical reappraisal
- (2019) Salem A. Beshyah et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Effects of Canagliflozin on Heart Failure Outcomes Associated with Preserved and Reduced Ejection Fraction in Type 2 Diabetes: Results from the CANVAS Program
- (2019) Gemma A. Figtree et al. CIRCULATION
- Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus
- (2019) Eri T. Kato et al. CIRCULATION
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety of Ramadan fasting in young patients with type 1 diabetes: A systematic review and meta‐analysis
- (2019) Huai Heng Loh et al. Journal of Diabetes Investigation
- Clinical Management of Intermittent Fasting in Patients with Diabetes Mellitus
- (2019) Martin M. Grajower et al. Nutrients
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2019) Mansoor Husain et al. NEW ENGLAND JOURNAL OF MEDICINE
- The effects of Ramadan fasting on clinical and biochemical markers among hemodialysis patients: A prospective cohort study
- (2019) Emad Khazneh et al. PLoS One
- Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes
- (2019) Julio Rosenstock et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Fasting during the holy month of Ramadan among older children and adolescents with type 1 diabetes in Kuwait
- (2019) Kholoud Mohamed et al. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
- Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial
- (2019) David R Matthews et al. LANCET
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2019) John B. Buse et al. DIABETOLOGIA
- Adrenaline and cortisol levels are lower during nighttime than daytime hypoglycaemia in children with type 1 diabetes
- (2018) S Fredheim et al. ACTA PAEDIATRICA
- Original paper: Efficacy and safety analysis of insulin degludec/insulin aspart compared with biphasic insulin aspart 30: A phase 3, multicentre, international, open-label, randomised, treat-to-target trial in patients with type 2 diabetes fasting during Ramadan
- (2018) Mohamed Hassanein et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The effect of Ramadan fasting and continuing sodium-glucose co-transporter-2 (SGLT2) inhibitor use on ketonemia, blood pressure and renal function in Muslim patients with type 2 diabetes
- (2018) Yanli Shao et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Do sulphonylureas still have a place in clinical practice?
- (2018) Kamlesh Khunti et al. Lancet Diabetes & Endocrinology
- Diabetes structured self-management education programmes: a narrative review and current innovations
- (2018) Sudesna Chatterjee et al. Lancet Diabetes & Endocrinology
- Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2018) Melanie J. Davies et al. DIABETES CARE
- Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2018) Melanie J. Davies et al. DIABETOLOGIA
- Initial increase in glucose variability during Ramadan fasting in non-insulin-treated patients with diabetes type 2 using continuous glucose monitoring
- (2018) Nesreen Aldawi et al. Libyan Journal of Medicine
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- The effect of Ramadan fasting during pregnancy on perinatal outcomes: a systematic review and meta-analysis
- (2018) Jocelyn D. Glazier et al. BMC Pregnancy and Childbirth
- Tolerability of canagliflozin in patients with type 2 diabetes mellitus fasting during Ramadan: Results of the Canagliflozin in Ramadan Tolerance Observational Study (CRATOS)
- (2017) Mohamed Hassanein et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes
- (2017) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
- (2017) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ramadan fasting in Saudi Arabia is associated with altered expression of CLOCK, DUSP and IL-1alpha genes, as well as changes in cardiometabolic risk factors
- (2017) Ghada M. A. Ajabnoor et al. PLoS One
- Safety and efficacy of a glucagon-like peptide-1 receptor agonist added to basal insulin therapy versus basal insulin with or without a rapid-acting insulin in patients with type 2 diabetes: results of a meta-analysis
- (2017) Carol H. Wysham et al. POSTGRADUATE MEDICINE
- Flash glucose monitoring system may benefit children and adolescents with type 1 diabetes during fasting at Ramadan
- (2017) Abdulmoein Al-Agha et al. SAUDI MEDICAL JOURNAL
- Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management
- (2017) Arun Chaudhury et al. Frontiers in Endocrinology
- Switching from sulphonylurea to a sodium-glucose cotransporter2 inhibitor in the fasting month of Ramadan is associated with a reduction in hypoglycaemia
- (2016) W. J. Wan Seman et al. DIABETES OBESITY & METABOLISM
- Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double-blind randomized controlled trial (BEGIN: ADD TO GLP-1 Study)
- (2016) V. R. Aroda et al. DIABETES OBESITY & METABOLISM
- Efficacy and safety of liraglutide compared to sulphonylurea during Ramadan in patients with type 2 diabetes (LIRA-Ramadan): a randomized trial
- (2016) S. T. Azar et al. DIABETES OBESITY & METABOLISM
- Sodium-glucose co-transporter 2 inhibitors in addition to insulin therapy for management of type 2 diabetes mellitus: A meta-analysis of randomized controlled trials
- (2016) Huilin Tang et al. DIABETES OBESITY & METABOLISM
- Guidelines for managing diabetes in Ramadan
- (2016) S. Ali et al. DIABETIC MEDICINE
- Theory-based self-management educational interventions on patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
- (2016) Fang-Fang Zhao et al. JOURNAL OF ADVANCED NURSING
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diabetes self-management education for adults with type 2 diabetes mellitus: A systematic review of the effect on glycemic control
- (2016) Carole A. Chrvala et al. PATIENT EDUCATION AND COUNSELING
- Patients' management of type 2 diabetes in Middle Eastern countries: review of studies
- (2016) Zahra Khalil Alsairafi et al. Patient Preference and Adherence
- Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysis
- (2016) Francesco Salvo et al. BMJ-British Medical Journal
- Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysis
- (2016) Francesco Salvo et al. BMJ-British Medical Journal
- Nutritional Education Needs in Relation to Ramadan Fasting and Its Complications in Tehran, Iran
- (2016) Zhaleh Shadman et al. Iranian Red Crescent Medical Journal
- Effects of vildagliptin relative to sulfonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: influence of age and treatment with/without metformin in the VIRTUE study
- (2016) Ahmed Hassoun et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Glucose excursions and glycaemic control during Ramadan fasting in diabetic patients: Insights from continuous glucose monitoring (CGM)
- (2015) N. Lessan et al. DIABETES & METABOLISM
- Diabetes Self-management Education and Support in Type 2 Diabetes: A Joint Position Statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics
- (2015) Margaret A. Powers et al. DIABETES CARE
- Impact of empagliflozin added on to basal insulin in type 2 diabetes inadequately controlled on basal insulin: a 78-week randomized, double-blind, placebo-controlled trial
- (2015) J. Rosenstock et al. DIABETES OBESITY & METABOLISM
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ramadan fasting and newborn's birth weight in pregnant Muslim women in The Netherlands
- (2014) Ary I. Savitri et al. BRITISH JOURNAL OF NUTRITION
- Beliefs of People With Diabetes About Skin Prick During Ramadan Fasting
- (2014) Shabeen Naz Masood et al. DIABETES CARE
- Improved Glucose Control With Weight Loss, Lower Insulin Doses, and No Increased Hypoglycemia With Empagliflozin Added to Titrated Multiple Daily Injections of Insulin in Obese Inadequately Controlled Type 2 Diabetes
- (2014) Julio Rosenstock et al. DIABETES CARE
- Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis
- (2014) Conrad Eng et al. LANCET
- Health Impact of Fasting in Saudi Arabia during Ramadan: Association with Disturbed Circadian Rhythm and Metabolic and Sleeping Patterns
- (2014) Ghada M. Ajabnoor et al. PLoS One
- A randomized controlled trial comparing the GLP-1 receptor agonist liraglutide to a sulphonylurea as add on to metformin in patients with established type 2 diabetes during Ramadan: the Treat 4 Ramadan Trial
- (2013) E. M. Brady et al. DIABETES OBESITY & METABOLISM
- The effect of vildagliptin relative to sulphonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: the VIRTUE study
- (2013) M. Al-Arouj et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Group based diabetes self-management education compared to routine treatment for people with type 2 diabetes mellitus. A systematic review with meta-analysis
- (2012) Aslak Steinsbekk et al. BMC HEALTH SERVICES RESEARCH
- Ramadan Prospective Diabetes Study: the role of drug dosage and timing alteration, active glucose monitoring and patient education
- (2012) M. Y. Ahmedani et al. DIABETIC MEDICINE
- The benefit of early treatment without rescreening in women with a history of gestational diabetes
- (2012) Nicola Maher et al. Journal of Maternal-Fetal & Neonatal Medicine
- Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study
- (2011) Mohamed Hassanein et al. CURRENT MEDICAL RESEARCH AND OPINION
- Hypoglycaemia in sulphonylurea-treated subjects with type 2 diabetes undergoing Ramadan fasting: a five-country observational study
- (2011) S.R. Aravind et al. CURRENT MEDICAL RESEARCH AND OPINION
- Glycemic indices of five varieties of dates in healthy and diabetic subjects
- (2011) Juma M Alkaabi et al. Nutrition Journal
- Secular increase in placental weight in Saudi Arabia
- (2011) S.H. Alwasel et al. PLACENTA
- Recommendations for Management of Diabetes During Ramadan: Update 2010
- (2010) M. Al-Arouj et al. DIABETES CARE
- Ramadan Education and Awareness in Diabetes (READ) programme for Muslims with Type 2 diabetes who fast during Ramadan
- (2010) V. Bravis et al. DIABETIC MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now